DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Lip GY, Skjøth F, Nielsen PB, Larsen TB.
Non-valvular atrial fibrillation patients with none or one additional risk factor of the CHA2DS2-VASc score. A comprehensive net clinical benefit analysis for warfarin, aspirin, or no therapy.
Thromb Haemost 2015;
114 (04) 826-834
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.